Although not statistically significant in patients with grade II or III glioma, patients with GBM in the first DKK3 tertile showed significantly greater OS and PFS rates than those in the second and third tertiles (Fig. 4A and B). This evidence concerns the gene DKK3 and central nervous system cancer.